A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

In a collaborative interdisciplinary study, Michael Mitchell of the School of Engineering and Applied Science, Wei Guo of the School of Arts & Sciences, and Drew Weissman of the Perelman School of ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

The autoimmune response in AIH may be triggered by molecular mimicry, where T cells mistakenly attack host proteins. The presence of autoantibodies and antigen-specific cytotoxic T cells exacerbates ...

Unlike T cells, NK cells can identify and eliminate malignant cells ... which guide their progression from hematopoietic stem ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

The following is a summary of “Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European ...

Human innate immune cells that “remember” previous stimulation could provide new insights into chronic inflammatory diseases.